Radioactive Iodine Therapy (Iodine I-131) for Thyroid Cancer

Precision Treatment for Thyroid Cancer

United Theranostics specializes in advanced radiopharmaceutical therapies, including Radioactive Iodine (I-131) therapy, for the effective treatment of thyroid cancer. Our approach leverages molecular imaging and targeted therapy to deliver precise care, minimize side effects, and improve patient outcomes.

Request An Appointment

Why Choose Iodine I-131 Therapy?

Highly Targeted: I-131 is selectively absorbed by thyroid tissue, allowing for focused destruction of cancerous or residual thyroid cells while sparing healthy tissue.
Proven Effectiveness: Decades of clinical experience support its role as a standard of care for certain types of thyroid cancer.
Minimally Invasive: Administered as a simple oral capsule or liquid, typically requiring only a brief outpatient visit or short hospital stay.
Personalized Treatment: Dosage and protocols are tailored to each patient’s specific condition and needs.

How the Therapy Works

Eligibility and Preparation: Patients are evaluated to determine suitability for I-131 therapy. Preparation may include dietary restrictions and medication adjustments to maximize treatment effectiveness.
Administration: I-131 is given orally. The radioisotope is absorbed by thyroid tissue, delivering targeted radiation to destroy cancerous or remaining thyroid cells.
Radiation Precautions: Patients may need to follow specific radiation safety guidelines for a short period after treatment to protect others from exposure.
Follow-Up: Ongoing monitoring with laboratory tests and imaging ensures effectiveness and guides further care.

Who Can Benefit?

Patients with differentiated thyroid cancers (papillary or follicular) following thyroidectomy.
Individuals with thyroid cancer recurrence or metastases that absorb iodine.
Patients requiring ablation of residual thyroid tissue post-surgery.

Frequently Asked Questions (FAQ)

B
C

What is Radioactive Iodine (I-131) therapy?

Radioactive Iodine (I-131) therapy uses a small amount of radioactive iodine to destroy thyroid tissue or thyroid cancer cells that remain after surgery.
B
C

Who is eligible for I-131 therapy?

Most often, patients with papillary or follicular thyroid cancer benefit from I-131 therapy. Eligibility is determined based on pathology, imaging, and lab results.
B
C

How is the treatment given?

I-131 is administered orally, either as a capsule or liquid. The procedure is quick and typically does not require anesthesia.
B
C

Will I need to stay in the hospital?

Some patients may be treated as outpatients, while others may need a short hospital stay, depending on the dose and local regulations.
B
C

Are there side effects?

Most patients tolerate I-131 well. Possible side effects include dry mouth, altered taste, neck discomfort, mild nausea, or temporary changes in blood counts. Long-term risks are rare but can include reduced salivary gland function or secondary cancers.
B
C

Are there special precautions after therapy?

Yes. You’ll be given instructions to limit close contact with others, especially children and pregnant women, for a few days after treatment to minimize radiation exposure.
B
C

How soon can I resume normal activities?

Most patients return to normal routines within a few days, following the recommended safety guidelines.
B
C

Will my insurance cover this therapy?

United Theranostics assists with insurance verification and can help identify financial assistance programs if needed.
B
C

How is my response to therapy monitored?

Follow-up includes blood tests (such as thyroglobulin) and imaging studies to assess the effectiveness of treatment and guide further care.
B
C

Where is this therapy available?

Radioactive Iodine (I-131) therapy is available at United Theranostics facilities across New York, New Jersey, Pennsylvania, Maryland, and New Mexico.

United Theranostics: Precision Oncology, Personalized Care

Expertise: Leaders in molecular imaging and targeted radiopharmaceutical therapies for thyroid cancer.
Comprehensive Support: Guidance through every step, from consultation to follow-up.
Regional Access: Multiple facilities for convenient, advanced care.

Take the Next Step

If you or a loved one has thyroid cancer and may benefit from Radioactive Iodine (I-131) therapy, contact United Theranostics to schedule a personalized consultation.

Appointments & Consultations:

 

Contact Us